Thorax: Normal and benign pathologic patterns in FDG-PET/CT imaging

PET Clinics

Volumn 9, Issue 2, 2014, Pages 147-168

  Wachsmann, Jason W ^a   Gerbaudo, Victor H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Benign pathologic findings; Computed tomography; Infection; Inflammation; Normal biodistribution; Thorax

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; AMYLOIDOSIS; ARTICLE; BARRETT ESOPHAGUS; BENIGN TUMOR; CHEST INFECTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CYSTIC FIBROSIS; DRUG UPTAKE; ESOPHAGITIS; ESOPHAGUS TUMOR; FIBROELASTOMA; GREAT BLOOD VESSEL; HEART MUSCLE; HUMAN; INTERSTITIAL LUNG DISEASE; PHYSICAL DISEASE BY BODY FUNCTION; PNEUMOCONIOSIS; PRIORITY JOURNAL; SARCOIDOSIS; THORAX DISEASE; THORAX RADIOGRAPHY; TRACHEA DISEASE; VASCULITIS; CARDIAC MUSCLE; COMPUTER ASSISTED TOMOGRAPHY; GASTROINTESTINAL DISEASE; HEART DISEASE; INFECTION; LUNG DISEASE; MEDIASTINUM DISEASE; METABOLISM; MULTIMODAL IMAGING; PLEURA DISEASE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; SPINE DISEASE; THORACIC VERTEBRA; THORAX; THORAX INJURY; TISSUE DISTRIBUTION;

AMYLOIDOSIS; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; INFECTION; LUNG DISEASES; MEDIASTINAL DISEASES; MULTIMODAL IMAGING; MYOCARDIUM; PLEURAL DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; SPINAL DISEASES; THORACIC DISEASES; THORACIC INJURIES; THORACIC VERTEBRAE; THORAX; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898601337     PISSN: 15568598     EISSN: 18799809     Source Type: Journal    
DOI: 10.1016/j.cpet.2013.10.004     Document Type: Review

References (89)

1. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2 2004 305 332
2. M.W. Saif, I. Tzannou, and N. Makrilia et al. Role and cost effectiveness of PET/CT in management of patients with cancer Yale J Biol Med 83 2 2010 53 65
3. S.N. Yang, J.A. Liang, and F.J. Lin et al. Differentiating benign and malignant pulmonary lesions with FDG-PET Anticancer Res 21 6A 2001 4153 4157
4. A. Alavi, N. Gupta, and J.L. Alberini et al. Positron emission tomography imaging in nonmalignant thoracic disorders Semin Nucl Med 32 4 2002 293 321
5. L.O. Kapucu, C.C. Meltzer, and D.W. Townsend et al. Fluorine-18- fluorodeoxyglucose uptake in pneumonia J Nucl Med 39 7 1998 1267 1269
6. 18F-FDG uptake and breast density in women with normal breast tissue J Nucl Med 44 2003 1238 1242
7. S. Paidisetty, and T.M. Blodgett Brown fat: atypical locations and appearances encountered in PET/CT AJR Am J Roentgenol 193 2 2009 359 366
8. P.D. Shreve, Y. Anzai, and R.L. Wahl Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 1 1999 61 77
9. A. Shammas, R. Lim, and M. Charron Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions Radiographics 29 5 2009 1467 1486
10. S.F. Barrington, and M.N. Maisey Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam J Nucl Med 37 7 1996 1127 1129
11. S. Yasuda, M. Ide, and S. Takagi et al. Elevated F-18 FDG uptake in skeletal muscle Clin Nucl Med 23 2 1998 111 112
12. K. Nakatani, Y. Nakamoto, and K. Togashi Risk factors for extensive skeletal muscle uptake in oncologic FDG-PET/CT for patients undergoing a 4-h fast Nucl Med Commun 33 6 2012 648 655
13. F. Benard, D. Sterman, and R.J. Smith et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography Chest 114 3 1998 713 722
14. V.H. Gerbaudo, and B. Julius Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging Eur J Radiol 64 3 2007 401 405
15. T. Nakahara, H. Fujii, and M. Ide et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT Br J Radiol 74 885 2001 821 824
16. 18F-FDG PET Radiographics 24 6 2004 1611 1616
17. 11C-methionine PET and FDG PET J Nucl Med 40 10 1999 1595 1601
18. 18F FDG uptake at oncologic PET/CT Radiographics 31 5 2011 1287 1305
19. G.A. Brigid, F.L. Flanagan, and F. Dehdashti Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations AJR Am J Roentgenol 169 1997 1675 1680
20. 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects Anticancer Res 21 1B 2001 701 706
21. 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology J Nucl Med 49 9 2008 1429 1436
22. M.Y. Jeung, A. Gangi, and B. Gasser et al. Imaging of chest wall disorders Radiographics 19 3 1999 617 637
23. C. Love, M.B. Tomas, and G.G. Tronco et al. FDG PET of infection and inflammation Radiographics 25 5 2005 1357 1368
24. O. Osinowo, O.A. Adebo, and A.O. Okbanjo Osteomyelitis of the ribs in Ibadan Thorax 41 1986 58 60
25. J.T. Mader, M. Shirtliff, and J.H. Calhoun The host and the skeletal infection: classification and pathogenesis of acute bacterial bone and joint sepsis Baillieres Best Pract Res Clin Rheumatol 13 1 1999 1 20
26. M.F. Termaat, P.G. Raijmakers, and H.J. Scholten et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis J Bone Joint Surg Am 87 11 2005 2464 2471
27. B. Ajdinovic, L. Jaukovic, and D. Antoniou Five benign myoskeletal diseases in paediatrics and the role of nuclear medicine. Do they differ from those in adults? Hell J Nucl Med 16 1 2013 2 8
28. P.E. Marik Aspiration pneumonitis and aspiration pneumonia N Engl J Med 344 9 2001 665 671
29. S. Asad, S.L. Aquino, and N. Piyavisetpat et al. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities AJR Am J Roentgenol 182 4 2004 983 989
30. K.A. Athanassiadi Infections of the mediastinum Thorac Surg Clin 19 1 2009 37 45
31. R.F. Yen, Y.C. Chen, and Y.W. Wu et al. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report Acad Radiol 11 3 2004 316 321
32. 18F-2-deoxyglucose positron emission tomography Circulation 113 1 2006 e4 e5
33. H. Takano, K. Nakagawa, and N. Ishio et al. Active myocarditis in a patient with chronic active Epstein-Barr virus infection Int J Cardiol 130 1 2008 e11 e13
34. G. Raghu, and K.K. Brown Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis Clin Chest Med 25 2004 409 419
35. 18F-FDG PET/CT J Nucl Med 50 4 2009 538 545
36. J. Capobianco, A. Grimberg, and B.M. Thompson et al. Thoracic manifestations of collagen vascular diseases Radiographics 32 1 2012 33 50
37. K.K. Brown Pulmonary vasculitis Proc Am Thorac Soc 3 1 2006 48 57
38. M. Reichert, and E.S. Bensadoun PET imaging in patients with coal workers pneumoconiosis and suspected malignancy J Thorac Oncol 4 2009 649 651
39. 18F-FDG PET imaging of progressive massive fibrosis Ann Nucl Med 24 2010 21 27
40. M. Ozkan, A. Ayan, and D. Arik et al. FDG PET findings in a case with acute pulmonary silicosis Ann Nucl Med 23 2009 883 886
41. H.A. Jacene, C. Cohade, and R.L. Wahl F-18 FDG PET/CT in acute respiratory distress syndrome: a case report Clin Nucl Med 29 12 2004 786 788
42. R.S. Rodrigues, P.R. Miller, and F.A. Bozza et al. FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report Intensive Care Med 34 12 2008 2273 2278
43. 18F]FDG uptake in healthy tissue and bone marrow J Appl Clin Med Phys 9 3 2008 2747
44. 18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients Radiother Oncol 104 1 2012 52 57
45. L. Kostakoglu, H. Agress Jr., and S.J. Goldsmith Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 2 2003 315 340
46. 18F-FDG in brown adipose tissue J Nucl Med 48 6 2007 981 986
47. C. Cohade Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect Semin Nucl Med 40 4 2010 283 293
48. D. Deandreis, S. Leboulleux, and C. Dromain et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation Radiology 258 1 2011 270 276
49. K.R. Carter, and E. Kotlyarov Common causes of false positive F18 FDG PET/CT scans in oncology Braz Arch Biol Technol 50 2007 29 35
50. G. El-Haddad, H. Zhuang, and N. Gupta et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders Semin Nucl Med 34 4 2004 313 329
51. B.H. Kwek, S.L. Aquino, and A.J. Fischman Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis Chest 125 2004 2356
52. 18FDG-PET to discriminate between infection and rejection in lung transplant recipients Transplantation 77 9 2004 1462 1464
53. 18F-FDG PET during acute lung injury AJR Am J Roentgenol 195 2 2010 292 300
54. 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 12 2004 1989 1998
55. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2 2012 241 248
56. J.M. Torpy, C. Lynm, and R.M. Glass JAMA patient page. Cystic fibrosis JAMA 302 10 2009 1130
57. R. Amin, M. Charron, and L. Grinblat et al. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT Radiology 264 3 2012 868 875
58. National coverage determination (NCD) for positron emission tomography (PET) scans (220.6). 2009. Available at: http://www.cms.gov/medicare-coverage- database/details/ncd-details.aspx?NCDId=211&ncdver=4&NCAId=92&ver= 19&NcaName=Positron+Emission+Tomography+&bc=BEAAAAAAIAAA&. Accessed February 21, 2013.
59. D. Ost, A.M. Fein, and S.H. Feinsilver Clinical practice: the solitary pulmonary nodule N Engl J Med 348 2003 2535 2542
60. 18F-FDG PET versus nodule-enhancement CT AJR Am J Roentgenol 187 5 2006 1361 1367
61. J.J. Erasmus, J.E. Connolly, and H.P. McAdams et al. Solitary pulmonary nodules: part I. Morphologic evaluation for differentiation of benign and malignant lesions Radiographics 20 1 2000 43 58
62. T. Bunyaviroch, and R.E. Coleman PET evaluation of lung cancer J Nucl Med 47 3 2006 451 469
63. Centers for Disease Control and Prevention. Accidents/unintentional injuries. CDC Web site. Available at: http://www.cdc.gov/nchs/FASTATS/acc-inj. htm. Accessed February 24, 2013.
64. K.L. Mattox, and M.J. Wall Jr. Newer diagnostic measures and emergency management Chest Surg Clin N Am 7 2 1997 213 226
65. P.V. Kavanagh, A.W. Stevenson, and M.Y. Chen et al. Nonneoplastic diseases in the chest showing increased activity on FDG PET AJR Am J Roentgenol 183 4 2004 1133 1141
66. 18F-FDG positron emission tomography Br J Radiol 79 939 2006 264 265
67. M. Soussan, P.Y. Brillet, and H. Nunes et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis J Nucl Cardiol 20 1 2013 120 127
68. 18F-FDG PET-CT J Nucl Cardiol 19 4 2012 807 810
69. A.F. Schinkel, J.J. Bax, and D. Poldermans et al. Hibernating myocardium: diagnosis and patient outcomes Curr Probl Cardiol 32 7 2007 375 410
70. G.D. Vitale, R.A. deKemp, and T.D. Ruddy et al. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction J Nucl Med 42 12 2001 1730 1736
71. T. Hayashida, E. Sueyoshi, and I. Sakamoto et al. PET features of aortic diseases AJR Am J Roentgenol 195 1 2010 229 233
72. 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J Nucl Med 50 4 2009 563 568
73. 18F-FDG PET/CT J Nucl Med 51 5 2010 686 691
74. 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome J Nucl Med 51 5 2010 674 681
75. G. Hagan, M. Southwood, and C. Treacy et al. (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: a proof-of-principle study Pulm Circ 1 4 2011 448 455
76. 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions AJR Am J Roentgenol 191 2 2008 515 521
77. M. Takechi, S. Yasuda, and O. Chino et al. Physiologic FDG uptake in the esophagus J Nucl Med 49 Suppl 1 2008 260P
78. V. Conteduca, D. Sansonno, and G. Ingravallo et al. Barrett's esophagus and esophageal cancer: an overview Int J Oncol 41 2 2012 414 424
79. 18FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results J Nucl Med 45 11 2004 1804 1810
80. G.S. Meirelles, G. Ravizzini, and H.W. Yeung et al. Esophageal leiomyoma: a rare cause of false-positive FDG scans Clin Nucl Med 31 2006 342 344
81. C.M. Park, J.M. Goo, and H.J. Lee et al. Tumors in the tracheobronchial tree: CT and FDG PET features Radiographics 29 1 2009 55 71
82. M. Charest, C. Sirois, and Y. Cartier et al. Infected tracheal diverticulum mimicking an aggressive mediastinal lesion on FDG PET/CT: an interesting case with review of the literature Br J Radiol 85 1009 2012 e17 e21
83. S. De, and S. De Post intubation tracheal stenosis Indian J Crit Care Med 12 4 2008 194 197
84. M. Sato, T. Hiyama, and T. Abe et al. F-18 FDG PET/CT in relapsing polychondritis Ann Nucl Med 24 9 2010 687 690
85. F. De Geeter, and S.J. Vandecasteele Fluorodeoxyglucose PET in relapsing polychondritis N Engl J Med 358 5 2008 536 537
86. J.C. Pierce 3rd, and R. Henderson Hypermetabolism of elastofibroma dorsi on PET-CT AJR Am J Roentgenol 183 1 2004 35 37
87. Y. Umeda, Y. Demura, and N. Takeda et al. FDG-PET findings of nodular pulmonary amyloidosis with a long-term observation Nihon Kokyuki Gakkai Zasshi 45 5 2007 424 429 [in Japanese]
88. J.H. Seo, S.W. Lee, and B.C. Ahn et al. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT Lung Cancer 67 3 2010 376 379
89. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review Amyloid 19 2 2012 94 98